Literature DB >> 15640457

Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.

Maureen T Timlin1, Elizabeth J Parks.   

Abstract

BACKGROUND: Recent data suggest that hepatic de novo lipogenesis (DNL) is elevated in the fed state compared with the fasting state, but the rate at which lipogenesis can increase with meal consumption is currently unknown.
OBJECTIVE: The objective was to quantify the diurnal pattern of lipogenesis after 2 consecutive mixed meals were fed to healthy men (n = 8).
DESIGN: A liquid diet was administered after a 12-h fast. During the fasting and postprandial periods, serum insulin, glucose, triacylglycerol, and nonesterified fatty acid concentrations were measured, and rates of DNL were quantified via intravenous infusion of [1-(13)C] sodium acetate and mass isotopomer distribution analysis.
RESULTS: The temporal pattern of postprandial lipogenesis was similar in all subjects. Lipogenesis rose significantly from 4.7 +/- 3.3% at fasting, peaked at 18.2 +/- 7.1% after meal 1 (P = 0.003 compared with fasting), rose further to 23.1 +/- 8.9% after meal 2 (P = 0.01 for difference between meals), and then decreased toward baseline (P < 0.001). Lipogenesis peaked 4.2 h after the meals; lipoprotein-triacylglycerol concentrations peaked sooner, 2.0 h after the meals (P < 0.02). Maximum postprandial DNL ranged from 10.3% to 37.5%. Peak insulin concentrations after meal 1 correlated with peak DNL (R = 0.838, P = 0.037), although the leanest subjects had some of the highest rates of postprandial DNL.
CONCLUSION: These data confirm the acute stimulation of DNL after meals in healthy subjects and validate the contribution of this pathway to elevations in triacylglycerol concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640457     DOI: 10.1093/ajcn/81.1.35

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  45 in total

Review 1.  Prescribing aerobic exercise for the regulation of postprandial lipid metabolism : current research and recommendations.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 2.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

3.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.

Authors:  J Barr; J Caballería; I Martínez-Arranz; A Domínguez-Díez; C Alonso; J Muntané; M Pérez-Cormenzana; C García-Monzón; R Mayo; A Martín-Duce; M Romero-Gómez; O Lo Iacono; J Tordjman; R J Andrade; M Pérez-Carreras; Y Le Marchand-Brustel; A Tran; C Fernández-Escalante; E Arévalo; M García-Unzueta; K Clement; J Crespo; P Gual; M Gómez-Fleitas; M L Martínez-Chantar; A Castro; S C Lu; M Vázquez-Chantada; J M Mato
Journal:  J Proteome Res       Date:  2012-03-15       Impact factor: 4.466

4.  Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.

Authors:  Shinji Tamura; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Leptin decreases de novo lipogenesis in patients with lipodystrophy.

Authors:  Annah P Baykal; Elizabeth J Parks; Robert Shamburek; Majid M Syed-Abdul; Shaji Chacko; Elaine Cochran; Megan Startzell; Ahmed M Gharib; Ronald Ouwerkerk; Khaled Z Abd-Elmoniem; Peter J Walter; Mary Walter; Ranganath Muniyappa; Stephanie T Chung; Rebecca J Brown
Journal:  JCI Insight       Date:  2020-07-23

7.  Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.

Authors:  A Kotronen; V R Velagapudi; L Yetukuri; J Westerbacka; R Bergholm; K Ekroos; J Makkonen; M-R Taskinen; M Oresic; H Yki-Järvinen
Journal:  Diabetologia       Date:  2009-02-13       Impact factor: 10.122

8.  PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease.

Authors:  James P Hardwick; Douglas Osei-Hyiaman; Homer Wiland; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  PPAR Res       Date:  2010-03-16       Impact factor: 4.964

9.  Highly sensitive quantification of serum malonate, a possible marker for de novo lipogenesis, by LC-ESI-MS/MS.

Authors:  Akira Honda; Kouwa Yamashita; Tadashi Ikegami; Takashi Hara; Teruo Miyazaki; Takeshi Hirayama; Mitsuteru Numazawa; Yasushi Matsuzaki
Journal:  J Lipid Res       Date:  2009-04-29       Impact factor: 5.922

10.  Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein.

Authors:  James P Warne; Jillian M Varonin; Sofie S Nielsen; Louise E Olofsson; Christopher B Kaelin; Streamson Chua; Gregory S Barsh; Suneil K Koliwad; Allison W Xu
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.